Download

Full Text

1

CITATION

1 Total citation

0 Recent citations

0.38 Field Citation Ratio

0.1 Relative Citation Ratio

• Davies, N.G., Barnard, R.C., Jarvis, C.I., Kucharski, A.J., Munday, J., Pearson, C.A.B., Russell, T.W., Tully, D.C., Abbott, S., Gimma, A., Waites, W., Wong, K.L.M., van Zandvoort, K., Eggo, R.M., Funk, S., Jit, M., Atkins, K.E., Edmunds, W.J., Houben, R., Meakin, S.R., Quilty, B.J., Liu, Y., Flasche, S., Lei, J., Sun, F.Y., Krauer, F., Lowe, R., Bosse, N.I., Nightingale, E.S., Sherratt, K., Abbas, K., O'Reilly, K., Gibbs, H.P., Villabona-Arenas, C.J., Waterlow, N.R., Medley, G., Brady, O., Williams, J., Rosello, A., Klepac, P., Koltai, M., Sandmann, F.G., Foss, A.M., Jafari, Y., Prem, K., Chan, Y.W.D., Hellewell, J., Procter, S.R., Jombart, T., Knight, G.M., Endo, A., Quaife, M., Showering, A., Clifford, S., Estimated transmissibility and severity of novel SARS-CoV-2 Variant of Concern 202012/01 in England. medRxiv, 2020, 10.1101/2020.12.24.20248822.
• Lauring, A.S., Hodcroft, E.B., Genetic Variants of SARS-CoV-2 - What Do They Mean?. JAMA - J. Am. Med. Assoc., 2021, 10.1001/jama.2020.27124.
• Tang, J.W., Tambyah, P.A., Hui, D.S., Emergence of a new SARS-CoV-2 variant in the UK. J. Infect., 2021, 10.1016/j.jinf.2020.12.024.
• Tegally, H., Wilkinson, E., Giovanetti, M., Iranzadeh, A., Fonseca, V., Giandhari, J., Doolabh, D., Pillay, S., San, E.J., Msomi, N., Mlisana, K., von Gottberg, A., Walaza, S., Allam, M., Ismail, A., Mohale, T., Glass, A.J., Engelbrecht, S., van Zyl, G., Preiser, W., Petruccione, F., Sigal, A., Hardie, D., Marais, G., Hsiao, M., Korsman, S., Davies, M.A., Tyers, L., Mudau, I., York, D., Maslo, C., Goedhals, D., Abrahams, S., Laguda-Akingba, O., Alisoltani-Dehkordi, A., Godzik, A., Wibmer, C.K., Sewell, B.T., Lourenço, J., Alcantara, L.C.J., Kosakovsky Pond, S.L., Weaver, S., Martin, D., Lessells, R.J., Bhiman, J.N., Williamson, C., de Oliveira, T., Emergence and rapid spread of a new severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) lineage with multiple spike mutations in South Africa. medRxiv, 2020, 10.1101/2020.12.21.20248640.
• Voloch, C.M., da Silva Francisco, R., de Almeida, L.G.P., Cardoso, C.C., Brustolini, O.J., Gerber, A.L., Guimarães, A.P.de C., Mariani, D., da Costa, R.M., Ferreira, O.C., Frauches, T.S., de Mello, C.M.B., Leitão, I.de C., Galliez, R.M., Faffe, D.S., Castiñeiras, T.M.P.P., Tanuri, A., de Vasconcelos, A.T.R., Genomic characterization of a novel SARS-CoV-2 lineage from Rio de Janeiro, Brazil. J. Virol., 2021, 10.1128/JVI.00119-21 .
• Perchetti, G.A., Zhu, H., Mills, M.G., Shrestha, L., Mohamed Bakhash, S., Lin, M., Xie, H., Huang, M.L., Bedford, T., Jerome, K.R., Greninger, A.L., 2021. Specific allelic discrimination of N501Y and other SARS-CoV-2 mutations by ddPCR 1 detects B.1.1.7 lineage in Washington State 2 3 Running Title: ddPCR assay for SARS-CoV-2 N501Y mutation 32. medRxiv, 03, 2021, 10.1101/2021.03.10.21253321 10.21253321.
• Vogels, C.B., Breban, M.I., Alpert, T., Petrone, M.E., Watkins, A.E., Ott, I.M., Goes de Jesus, J., Morales Claro, I., Magalhães Ferreira, G., Crispim, M.A., CADDE Genomic Network, B.-.U., Singh, L., Tegally, H., Anyaneji, U.J., Hodcroft, E.B., Mason, C.E., Khullar, G., Metti, J., Dudley, J.T., MacKay, M.J., Nash, M., Wang, J., Liu, C., Hui, P., Murphy, S., Neal, C., Laszlo, E., Landry, M.L., Muyombwe, A., Downing, R., Razeq, J., de Oliveira, T., Faria, N.R., Sabino, E.C., Neher, R.A., Fauver, J.R., Grubaugh, N.D., 2021a. PCR assay to enhance global surveillance for SARS-CoV-2 variants of concern. medRxiv, 2021, 10.1101/2021.01.28.21250486 01.28.21250486.
• Vogels, C.B., Fauver, J., Grubaugh, N., Multiplexed RT-qPCR to screen for SARS-COV-2 B1.1.7, B.1.351, and P.1 variants of concern V.3 Coronavirus Method Development Community. medrxiv, 2021, 10.17504/protocols.io.br9vm966.
• Artesi, M., Bontems, S., Göbbels, P., Franckh, M., Maes, P., Boreux, R., Meex, C., Melin, P., Hayette, M.P., Bours, V., Durkin, K., A recurrent mutation at position 26340 of SARS-CoV-2 is associated with failure of the E Gene quantitative reverse transcription-PCR utilized in a commercial dual-target diagnostic assay. J. Clin. Microbiol., 58, 2020, 10.1128/JCM.01598-20.